H.R. 4366 - Consolidated Appropriations Act of FY 2024 - Issues related to health care policy provisions included in the bill writ large.
H.R. 2882 - Further Consolidated Appropriations Act of FY 2024 - Issues related to funding of the Department of Health and Human Services and agencies governing Medicare, Medicaid and other health care programs.
S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable.
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules, promulgation of the IRA and other issues impacting Medicare beneficiaries' ability to fully access their coverage.
Issues related improving outcomes and access in mental and behavioral health in America.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality health care coverage.
H.R. 4366 - Consolidated Appropriations Act of FY 2024 - Issues related to health care policy provisions included in the bill writ large.
H.R. 2882 - Further Consolidated Appropriations Act of FY 2024 - Issues related to funding of the Department of Health and Human Services and agencies focused on Medicare, Medicaid and other health care programs.
S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable.
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules.
Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces.
Duration: March 1, 2011
to
present
General Issues: Health Issues , Medicare/Medicaid , Taxation/Internal Revenue Code , Insurance
Spending: about $3,517,500 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2011: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS),, Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Melanie Nathanson Policy Analyst, Sr. Policy Advisor- Sen. Bob Graham
Senior Legislative Assistant - Rep. Sander Levin
Megan Hauck Pd Intern, LC, Scheduler,LA,Pol. Advsr.-Sen Don Nickles
Deputy Asst. Secretary - DHHS
Special Asst. to POTUS -White House
Sr. Policy Advisor - Senator Mitch McConnell
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on April 7.
Original Filing: 301547015.xml
Lobbying Issues
H.R. 4366 - Consolidated Appropriations Act of FY 2024 - Issues related to health care policy provisions included in the bill writ large.
H.R. 2882 - Further Consolidated Appropriations Act of FY 2024 - Issues related to funding of the Department of Health and Human Services and agencies governing Medicare, Medicaid and other health care programs.
S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable.
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules, promulgation of the IRA and other issues impacting Medicare beneficiaries' ability to fully access their coverage.
Issues related improving outcomes and access in mental and behavioral health in America.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality health care coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4366 - Consolidated Appropriations Act of FY 2024 - Issues related to health care policy provisions included in the bill writ large.
H.R. 2882 - Further Consolidated Appropriations Act of FY 2024 - Issues related to funding of the Department of Health and Human Services and agencies focused on Medicare, Medicaid and other health care programs.
S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable.
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules.
Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Dec. 31, 2023.
Original Filing: 301521048.xml
Lobbying Issues
HR 6363 - Further Continuing Appropriations and other Extenders Act - Support for critical government programs remaining operational and available.
HR 5860 - Continuing Appropriations Act of FY 2024 and other Extensions Act - Support for critical government programs remaining operational and available.
S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable.
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules, promulgation of the IRA and other issues impacting Medicare beneficiaries' ability to fully access their coverage.
Issues related improving outcomes and access in mental and behavioral health in America.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality health care coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 6363 - Further Continuing Appropriations and other Extenders Act - Support for critical government programs remaining operational and available.
HR 5860 - Continuing Appropriations Act of FY 2024 and other Extensions Act - Support for critical government programs remaining operational and available.
S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable.
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules.
Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Oct. 7, 2023.
Original Filing: 301498357.xml
Lobbying Issues
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the public and private sectors.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules, promulgation of the IRA and other issues impacting Medicare beneficiaries' ability to fully access their coverage.
Issues related improving outcomes and access in mental and behavioral health in America.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality health care coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program.
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules.
Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on July 18, 2023.
Original Filing: 301480430.xml
Lobbying Issues
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules.
Issues related improving outcomes and access in mental and behavioral health in America.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality health care coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces.
HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules.
Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on April 17, 2023.
Original Filing: 301453327.xml
Lobbying Issues
HHS and CMS Rules and Regulations focused on the Medicare Advantage program
Issues related improving outcomes and access in mental and behavioral health in America.
Issues related to developing coherent prior authorization methodologies.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality health care coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HHS and CMS Rules and Regulations focused on the Medicare Advantage program
Issues related improving outcomes and access in mental and behavioral health in public and private insurance.
Issues related to developing coherent authorization methodologies for mental health care in Medicare.
Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality health care coverage.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Jan. 2, 2023.
Original Filing: 301424607.xml
Lobbying Issues
HR 2617 - Consolidated Appropriations Act for Fiscal Year 2023 - Issues related to ensuring high quality/ high value benefits in the Medicare program, including expansion of Medicare coverage for mental health.
PL 117-169 - The Inflation Reduction Act of 2022 - Support for health care provisions included in the law.
HR 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for policies to improve the nation's mental health system.
Administration Regulations and Guidance focused on Medicare Advantage.
Senate Finance Committee and HELP Committee initiatives to improve the nation's mental health system.
Executive Orders related to ACA improvements.
Administration Policies focused on COVID-19 testing and treatment.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 2617 - Consolidated Appropriations Act for Fiscal Year 2023 - Issues related to ensuring high quality/ high value benefits in the Medicare program, including expansion of Medicare coverage for mental health.
HR 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for policies to improve the nation's mental health system.
Senate Finance Committee and HELP Committee initiatives to improve the nation's mental health system.
Executive Orders related to ACA improvements.
Administration Rules and Regulations focused on Medicare Advantage
Administration Policies focused on COVID-19 testing and treatment.
PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Oct. 8, 2022.
Original Filing: 301401990.xml
Lobbying Issues
PL 117-169 - The Inflation Reduction Act of 2022 - Support for health care provisions included in the law.
HR 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for policies to improve the nation's mental health system.
Administration Regulations and Guidance focused on Medicare Advantage.
Senate Finance Committee and HELP Committee initiatives to improve the nation's mental health system.
Executive Orders related to ACA improvements.
Administration Policies focused on COVID-19 testing and treatment.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
PL 117-169 - The Inflation Reduction Act of 2022 - Support for Medicare-related prescription drug policies including the delay of the Trump-era Medicare Rebate Rule.
HR 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for policies to improve the nation's mental health system.
Senate Finance Committee and HELP Committee initiatives to improve the nation's mental health system.
Executive Orders related to ACA improvements.
Administration Rules and Regulations focused on Medicare Advantage
Administration Policies focused on COVID-19 testing and treatment.
PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on July 2, 2022.
Original Filing: 301377158.xml
Lobbying Issues
HR 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for policies to improve the nation's mental health system.
Senate Finance Committee and HELP Committee initiatives to improve the nation's mental health system.
Executive Orders related to ACA improvements.
Administration Policies focused on COVID-19 testing and treatment.
Senate Reconciliation Bill Efforts - Health care elements, including policies regarding prescription drug prices, ACA improvements and improving maternal health.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 7666 - The Restoring Hope for Mental Health and Well Being Act of 2022 - Support for policies to improve the nation's mental health system.
Senate Finance Committee and HELP Committee initiatives to improve the nation's mental health system.
Executive Orders related to ACA improvements.
Administration Policies focused on COVID-19 testing and treatment.
PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Issues related to Medicare prescription drugs including the repeal of the Trump-era rebate rule and Medicare Part D restructuring.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on April 18, 2022.
Original Filing: 301358521.xml
Lobbying Issues
Executive Orders related to ACA improvements.
Administration Policies focused on COVID-19 testing and treatment.
H.R. 5376 - The Build Back Better Act - Health care elements of the bill including policies regarding prescription drug prices, ACA improvements and improving maternal health.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
H.R. 959/S.346 - The Momnibus Act of 2021 - Issues related to improving maternal health across America.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376 - Continued advocacy for elements of The Build Back Better Act - Health care elements of the bill including policies regarding prescription drug prices, ACA improvements and improving maternal health.
Executive Orders related to ACA improvements.
Administration Policies focused on COVID-19 testing and treatment.
PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder for Medicare beneficiaries.
Issues related to Medicare prescription drugs including the repeal of the Trump-era rebate rule and Medicare Part D restructuring.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Jan. 7, 2022.
Original Filing: 301320573.xml
Lobbying Issues
H.R. 5376 - The Build Back Better Act - Health care elements of the bill including policies regarding prescription drug prices, ACA improvements and improving maternal health.
H.R. 3684 - The Infrastructure Investment and Jobs Act - Issues related to delaying the Trump Era Rebate Rule.
S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act - Issues related to maintaining stability in the Medicare program.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
H.R. 959 - The Momnibus Act of 2021 - Issues related to improving maternal health across America.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 5376 - The Build Back Better Act - Health care elements of the bill including policies regarding prescription drug prices, ACA improvements and improving maternal health.
H.R. 3684 - The Infrastructure Investment and Jobs Act - Issues related to delaying the Trump Era Rebate Rule.
S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act - Issues related to maintaining stability in the Medicare program.
PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder for Medicare beneficiaries.
Issues related to Medicare prescription drugs including the repeal of the Trump-era rebate rule and Medicare Part D restructuring.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Oct. 12, 2021.
Original Filing: 301298054.xml
Lobbying Issues
Build Back Better Act - Health care elements of the bill including policies regarding prescription drug prices, ACA improvements and improving maternal health.
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
H.R. 959 - The Momnibus Act of 2021 - Issues related to improving maternal health across America.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Build Back Better Act - Health care elements of the bill including policies regarding prescription drug prices, ACA Marketplace improvements and improving maternal health.
PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder for Medicare beneficiaries.
Issues related to Medicare prescription drugs including the repeal of the Trump-era rebate rule and Medicare Part D restructuring.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on July 13, 2021.
Original Filing: 301275793.xml
Lobbying Issues
PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
H.R. 959 - The Momnibus Act of 2021 - Issues related to improving maternal health across America.
Agencies Lobbied
U.S. Senate
Lobbying Issues
PL 117-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder for Medicare beneficiaries.
Issues related to Medicare prescription drugs including the repeal of the Trump-era rebate rule and Medicare Part D restructuring.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on April 14, 2021.
Original Filing: 301253246.xml
Lobbying Issues
PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, increased access to coverage through enhanced marketplace subsidies, support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
Lobbying Issues
PL 177-2 - The American Rescue Plan Act - Issues related to the increased substance use disorder crisis in America, and support for vaccines, testing and telemedicine supports needed during the pandemic.
Issues related to increasing access to telehealth and audio-based medicine.
Work to identify better supports for people with behavioral health issues and substance use disorder.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Jan. 12, 2021.
Original Filing: 301230029.xml
Lobbying Issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing, telemedicine, support for the health sector, consumers and patients.
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Implementation - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Implementation - Issues related to funding for providers providing care for people with COVID-19.
H.R. 1865 - Consolidated Appropriations for FY 2020 - Issues related to the delay or repeal of the HIT tax.
S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications.
S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax.
Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs).
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Issues related to improving palliative and end of life care in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
P.L. 116-260/H.R. 133 - Consolidated Appropriations Act of 2021 - Issues related to the fight against COVID-19 including issues of vaccine distribution, testing, telemedicine, support for the health sector, consumers and patients in the Medicare Advantage program.
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Implementation- Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Implementation - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Implementation- Issues related to funding for providers providing care for people with COVID-19.
Trump Administration regulations regarding HHS risk adjustment data validation the Medicare programs.
H.R. 647/ S. 2080 - Issues related to improving palliative and end of life care through the Medicare program.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Oct. 14, 2020.
Original Filing: 301209790.xml
Lobbying Issues
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that health plans are able to support patients with the full battery of services needed during the COVID-19 pandemic.
Senate HEALS Act - Issues related to ensuring that health plans are able to support patients with the full battery of services needed during the COVID-19 pandemic.
H.R. 6800 - The Heroes Act - Issues related to ensuring coverage of both COVID and non-COVID related treatments, including telemedicine, during and following the pandemic.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
H.R. 1865 - Consolidated Appropriations for FY 2020 - Issues related to the delay or repeal of the HIT tax.
S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications.
S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax.
Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs).
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Issues related to improving palliative and end of life care in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 8319 - Continuing Appropriation Act 2021 - Ensuring that "health extenders" are addressed.
H.R. 8406 - The HEROES Act (modified) - Issues related to ensuring that health plans are able to support patients with the full battery of services needed during the COVID-19 pandemic.
Senate HEALS Act - Issues related to ensuring that health plans are able to support patients with the full battery of services needed during the COVID-19 pandemic.
H.R. 6800 - The Heroes Act - Issues related to ensuring coverage of both COVID and non-COVID related treatments, including telemedicine, during and following the pandemic in the Medicare Advantage program.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
Trump Administration regulations regarding HHS risk adjustment data validation the Medicare programs.
H.R. 647/ S. 2080 - Issues related to improving palliative and end of life care through the Medicare program.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on July 12, 2020.
Original Filing: 301186964.xml
Lobbying Issues
H.R. 1425 - Patient Protection and Affordable Care Enhancement Act - Issues related to strengthening marketplaces and increasing participation among plans and consumers in getting coverage.
H.R. 6800 - The Heroes Act - Issues related to ensuring coverage of both COVID and non-COVID related treatments, including telemedicine, during and following the pandemic.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
H.R. 1865 - Consolidated Appropriations for FY 2020 - Issues related to the delay or repeal of the HIT tax.
S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications.
S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax.
Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs).
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Issues related to improving palliative and end of life care in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6800 - The Heroes Act - Issues related to ensuring coverage of both COVID and non-COVID related treatments, including telemedicine, during and following the pandemic in the Medicare Advantage program.
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
Trump Administration regulations regarding HHS risk adjustment data validation the Medicare programs.
H.R. 647/ S. 2080 - Issues related to improving palliative and end of life care through the Medicare program.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on April 12, 2020.
Original Filing: 301165527.xml
Lobbying Issues
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
H.R. 1865 - Consolidated Appropriations for FY 2020 - Issues related to the delay or repeal of the HIT tax.
S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications.
S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax.
Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs).
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Issues related to improving palliative and end of life care in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response.
H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play.
H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19.
Trump Administration regulations regarding HHS risk adjustment data validation the Medicare programs.
H.R. 647/ S. 2080 - Issues related to improving palliative and end of life care through the Medicare program.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $80,000. The report was filed on Jan. 14, 2020.
Original Filing: 301105674.xml
Lobbying Issues
H.R. 1865 - Consolidated Appropriations for FY 2020 - Issues related to the delay or repeal of the HIT tax.
S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications.
S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax.
Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs).
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Issues related to improving palliative and end of life care in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Trump Administration regulations regarding HHS risk adjustment data validation the Medicare programs.
H.R. 647/ S. 2080 - Issues related to improving palliative and end of life care through the Medicare program.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $75,000. The report was filed on Oct. 16, 2019.
Original Filing: 301066356.xml
Lobbying Issues
S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications.
S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax.
Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs).
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Issues related to improving palliative and end of life care in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Trump Administration regulations regarding HHS risk adjustment data validation the Medicare programs.
Issues related to improving palliative and end of life care through the Medicare program.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $75,000. The report was filed on July 11, 2019.
Original Filing: 301044367.xml
Lobbying Issues
S. 1895 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications.
S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax.
Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs).
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Trump Administration regulations regarding the cost of prescription medication in the Medicare and Medicaid programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Issues related to improving palliative and end of life care in the United States.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Trump Administration regulations regarding prescription medications in the Medicare and Medicaid programs.
Issues related to improving palliative and end of life care through the Medicare program.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on April 5, 2019.
Original Filing: 301022892.xml
Lobbying Issues
Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare.
Issues related to stabilizing the health insurance marketplaces.
Issues related to insurance products such as AHPs and short term plans.
Trump Administration regulations regarding the cost of prescription medication in the Medicare and Medicaid programs
Trump Administration guidance and regulations regarding insurance marketplaces.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Trump Administration regulations regarding prescription medications in the Medicare and Medicaid programs.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Jan. 13, 2019.
Original Filing: 301004033.xml
Lobbying Issues
Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces.
P.L. 115-119- RAISE Family Care Givers Act - work on implementation of the law related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market.
Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Oct. 9, 2018.
Original Filing: 300983699.xml
Lobbying Issues
Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces.
P.L. 115-119- RAISE Family Care Givers Act - work on implementation of the law related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market.
Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on July 11, 2018.
Original Filing: 300963843.xml
Lobbying Issues
Department of Health and Human Services and Labor's rules regarding Associated Health Plans.
Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces.
P.L. 115-119- RAISE Family Care Givers Act - work on implementation of the law related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market.
Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on April 9, 2018.
Original Filing: 300943099.xml
Lobbying Issues
Departments of Health and Human Services and Labor's rules regarding Associated Health Plans.
Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces.
H.R.1625/PL-No.115 - Consolidated Appropriations Act of 2018 - Policy related to individual market stabilization.
H.R. 1301 - Continuing Resolution of 2018/PL 115-124- advocacy for the inclusion of the CHRONIC Act as well as repeal and/or delay of the Health Insurance Tax.
S. 1028/ H.R. 3759- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market.
Issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Departments of Health and Human Services and Labor's rules regarding Associated Health Plans.
Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces.
H.R.1625/PL-No.115 - Consolidated Appropriations Act of 2018 - Policy related to individual market stabilization.
H.R. 1301 - Continuing Resolution of 2018/PL 115-124- advocacy for the inclusion of the CHRONIC Act as well as repeal and/or delay of the Health Insurance Tax.
S. 1028/ H.R. 3759- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Jan. 14, 2018.
Original Filing: 300923616.xml
Lobbying Issues
Departments of Health and Human Services and Labor's rules regarding Associated Health Plans.
Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces.
H.R. 1 - Tax Cuts and Jobs Act - provisions regarding the repeal of the individual mandate in the individual insurance marketplaces.
H.R. 1370 - Continuing Resolution for FY 2018 - advocacy for the inclusion of the CHRONIC Act as well as repeal and/or delay of the Health Insurance Tax.
S. 1028/ H.R. 3759- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market.
Issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Departments of Health and Human Services (HHS) and Labor's rules regarding Associated Health Plans.
CMS regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces.
H.R. 1 - Tax Cuts and Jobs Act - provisions regarding the repeal of the individual mandate in the individual insurance marketplaces.
H.R. 1370 - Continuing Resolution for FY 2018 - advocacy for the inclusion of the CHRONIC Act as well as repeal and/or delay of the Health Insurance Tax.
Administrative regulations, rules and guidances related to Medicare Advantage and Medicare Part D.
S. 1028/H.R. 3759 - RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to beter integrating and improving palliative and end of life care into our nation's health care system.
Issues related to containing and decreasing prescription drug pricing for Medicare and Medicaid.
Issues related to making health care in the United States of America more transparent consumer-focused for Medicare and Medicaid beneficiaries.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Oct. 11, 2017.
Original Filing: 300902660.xml
Lobbying Issues
Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces.
H. R. 1628 - The American Health Care Act - issues impacting insurers participating in federal and state-based market places.
Better Care Reconciliation Act (Senate health reconciliation bill) - issues impacting insurers participating in federal and state-based exchanges.
S. 1028/ H.R. 3759- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system.
Rules and Regulations regarding 1332 waivers, AHPs and other issues impact the private insurance market.
Issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more transparent and consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrative regulations, rules and guidances related to Medicare Advantage and Medicare Part D.
H. R. 1628 - The American Health Care Act - issues impacting insurers participating in federal and state-based market places.
Better Care Reconciliation Act (Senate health reconciliation bill) - issues impacting insurers participating in federal and state-based exchanges.
Graham - Cassidy legislation to repeal and replace the Affordable Care Act. - issues impacting insurers participating in federal and state-based exchanges.
S. 1028/H.R. 3759 - RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to beter integrating and improving palliative and end of life care into our nation's health care system.
Issues related to containing and decreasing prescription drug pricing for Medicare and Medicaid.
Issues related to making health care in the United States of America more transparent consumer-focused for Medicare and Medicaid beneficiaries.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on July 12, 2017.
Original Filing: 300883693.xml
Lobbying Issues
Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces.
H. R. 1628 - The American Health Care Act - issues impacting insurers participating in federal and state-based market places.
Better Care Reconciliation Act (Senate health reconciliation bill) - issues impacting insurers participating in federal and state-based exchanges.
S. 1028- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to beter integrating and improving palliative and end of life care into our nation's health care system.
Issues related to containing and decreasing prescription drug costs to consumers.
Issues related to making health care in the United States of America more consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Administrative regulations, rules and guidances related to Medicare Advantage and Medicare Part D.
H. R. 1628 - The American Health Care Act - issues impacting insurers participating in federal and state-based market places.
Better Care Reconciliation Act (Senate health reconciliation bill) - issues impacting insurers participating in federal and state-based exchanges.
S. 1028- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work.
S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to beter integrating and improving palliative and end of life care into our nation's health care system.
Issues related to containing and decreasing prescription drug pricing for Medicare and Medicaid.
Issues related to making health care in the United States of America more consumer-focused for Medicare and Medicaid beneficiaries.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on April 5, 2017.
Original Filing: 300862805.xml
Lobbying Issues
Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces.
S. Con Res. 3 - Budget Resolution for FY 2017 - Issues realted to the future of treatment and federal involvement in the Affordable Care Act, both related to taxes and the marketplaces.
H. R. 1628 - The American Health Care Act - issues impacting insurers participating in federal and state-based market places.
Issues related to containing and decreasing prescription drug pricing.
Issues related to making health care in the United States of America more consumer-focused.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to containing and decreasing prescription drug pricing for Medicare and Medicaid.
Issues related to making health care in the United States of America more consumer-focused for Medicare and Medicaid beneficiaries.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Jan. 13, 2017.
Original Filing: 300846080.xml
Lobbying Issues
S. 3504 - Creating High Quality Results and Outcome Necessary to Improve Chronic Care Act of 2016 - Issues related to palliative care, telemedicine and other issues related to better serving Medicare beneficiaries.
H.R. 5327 - Continuing Appropriations and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs.
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 5555 "Personalize Your Care Act 2.0" - focused on improving end of life and palliative care in America.
Work surrounding the consumer experience across the private and public insurance spectrum.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Potential upcoming regulations applying to insurers in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 3504 - Creating High Quality Results and Outcome Necessary to Improve Chronic Care Act of 2016 - Issues related to palliative care, telemedicine and other issues related to better serving Medicare beneficiaries.
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 5555 "Personalize Your Care Act 2.0" - focused on improving end of life and palliative care in America.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Oct. 18, 2016.
Original Filing: 300829737.xml
Lobbying Issues
H.R. 5327 - Continuing Appropriatins and Military Construction, VA and Related Agencies Appropriations Act of 2017 and Zika Response and Preparedness Act. Issues regarding the funding of opioid related programs.
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 5555 "Personalize Your Care Act 2.0" - focused on improving end of life and palliative care in America.
Work surrounding the consumer experience across the private and public insurance spectrum.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Potential upcoming regulations applying to insurers in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 5555 "Personalize Your Care Act 2.0" - focused on improving end of life and palliative care in America.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on July 19, 2016.
Original Filing: 300813243.xml
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 5555 "Personalize Your Care Act 2.0" - focused on improving end of life and palliative care in America.
Work surrounding the consumer experience across the private and public insurance spectrum.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Potential upcoming regulations applying to insurers in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 5555 "Personalize Your Care Act 2.0" - focused on improving end of life and palliative care in America.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on April 14, 2016.
Original Filing: 300791460.xml
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
Upcoming H.R. "Personalize Your Care Act" focused on improving end of life and palliative care in America.
Work surrounding the consumer experience across the private and public insurance spectrum.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Advance Notice of Methodological Changes for(CY)2017 for MA, Part C and Part D payment policies and the 2017 call letter.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Potential upcoming regulations applying to insurers in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
Upcoming H.R. "Personalize Your Care Act" focused on improving end of life and palliative care in America.
Focus on elements of the Senate Finance Committee's work related to chronic care coverage in the Medicare program, with an emphasis on end of life and palliative care data provisions.
Advance Notice of Methodological Changes for(CY)2017 for MA, Part C and Part D payment policies and the 2017 call letter.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of the 3 Rs in the current ACA-environment.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Jan. 5, 2016.
Original Filing: 300769221.xml
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
Protecting Americans from Tax Hikes Act of 2015 (Included in H.R. 2029)- provisions related to the treatment of ACA-related taxes including the Health Insurers tax and the "Cadillac" tax.
H.R. 2507 - Increasing Regulatory Fairness Act of 2015 - issues related to strengthening the Medicare Advantage program and ensuring that the program is strengthened and amended in a thoughtful, data-driven manner.
H.R. 1624 - Protecting Affordable Care Coverage for Employees Act of 2015- a bill to address the stabilization of insurance for business with 51-100 employees.
Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS).
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Focused on issues related to the role of physicians and health care providers in delivery system reform and the role that health plans will take in changing the paradigm and payment structure in the Medicare program and in the private sector.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Issues related to upcoming regulations applying to the structure of the health insurer tax in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
S.Con.Res 11- The Senate Budget Resolution - Issues that could impact insurance plans, transparency, health IT, health care entitlements and private coverage.
H.Con. Res. 96 - The House Budget Resolution - Issues that could impact, insurance plans, transparency and health IT. health care entitlements and private coverage.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of risk corridors in the current ACA-environment.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS).
H.R. 2507 - Increasing Regulatory Fairness Act of 2015 - Issues related to data-driven changes to the Medicare Advantage program with a focus on Risk Adjustment and the Stars program.
H.R. 2- The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to physician reimbursement structure changes that can impact their interactions with health plans and delivery system reform.
CMS regulations related to payment and structure of Medicare Parts C and D as well as federal and state based Marketplaces.
HHS regulations related to health insurance market reforms.
Policies that would help to advance and improve access and coverage for palliative and end of life care in Medicare, Medicaid and the private insurance market.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Oct. 16, 2015.
Original Filing: 300754504.xml
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 2507 - Increasing Regulatory Fairness Act of 2015 - issues related to strengthening the Medicare Advantage program and ensuring that the program is strengthened and amended in a thoughtful, data-driven manner.
H.R. 1624 - Protecting Affordable Care Coverage for Employees Act of 2015- a bill to address the stabilization of insurance for business with 51-100 employees.
Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS).
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Focused on issues related to the role of physicians and health care providers in delivery system reform and the role that health plans will take in changing the paradigm and payment structure in the Medicare program and in the private sector.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Issues related to upcoming regulations applying to the structure of the health insurer tax in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
S.Con.Res 11- The Senate Budget Resolution - Issues that could impact insurance plans, transparency, health IT, health care entitlements and private coverage.
H.Con. Res. 96 - The House Budget Resolution - Issues that could impact, insurance plans, transparency and health IT. health care entitlements and private coverage.
Issues related to participation and coverage in state based market places.
Issues related to the treatment of risk corridors in the current ACA-environment.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS).
H.R. 2507 - Increasing Regulatory Fairness Act of 2015 - Issues related to data-driven changes to the Medicare Advantage program with a focus on Risk Adjustment and the Stars program.
H.R. 2- The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to physician reimbursement structure changes that can impact their interactions with health plans and delivery system reform.
CMS regulations related to payment and structure of Medicare Parts C and D as well as federal and state based Marketplaces.
HHS regulations related to health insurance market reforms.
Policies that would help to advance and improve access and coverage for palliative and end of life care in Medicare, Medicaid and the private insurance market.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on July 13, 2015.
Original Filing: 300733711.xml
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
H.R. 2507 - Increasing Regulatory Fairness Act of 2015 - issues related to strengthening the Medicare Advantage program and ensuring that the program is strengthened and amended in a thoughtful, data-driven manner.
Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS).
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Focused on issues related to the role of physicians and health care providers in delivery system reform and the role that health plans will take in changing the paradigm and payment structure in the Medicare program and in the private sector.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Issues related to upcoming regulations applying to the structure of the health insurer tax in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
S.Con.Res 11- The Senate Budget Resolution - Issues that could impact insurance plans, transparency, health IT, health care entitlements and private coverage.
H.Con. Res. 96 - The House Budget Resolution - Issues that could impact, insurance plans, transparency and health IT. health care entitlements and private coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1549 - The Care Planning Act - supporting advances in End-of-Life Care throughout the nation.
Support of the inclusion of Advanced Care Planning codes in the CMS Physician Fee Schedule (PFS).
H.R. 2507 - Increasing Regulatory Fairness Act of 2015 - Issues related to data-driven changes to the Medicare Advantage program with a focus on Risk Adjustment and the Stars program.
H.R. 2- The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to physician reimbursement structure changes that can impact their interactions with health plans and delivery system reform.
CMS regulations related to payment and structure of Medicare Parts C and D as well as federal and state based Marketplaces.
HHS regulations related to health insurance market reforms.
Policies that would help to advance and improve access and coverage for palliative and end of life care in Medicare, Medicaid and the private insurance market.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on April 13, 2015.
Original Filing: 300714533.xml
Lobbying Issues
H.R. 2 - The Medicare Access and CHIP Reauthorization Act of 2015 - Focused on issues related to the role of physicians and health care providers in delivery system reform and the role that health plans will take in changing the paradigm and payment structure in the Medicare program and in the private sector.
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Issues related to upcoming regulations applying to the structure of the health insurer tax in the Affordable Care Act.
Issues regarding strengthening, advancing and improving patient and provider options for palliative and end of life care in Medicare, Medicaid and private insurance. Both legislative and regulatory work.
Regulatory issues regarding coverage, payment and plan design issues related to Medicare Parts C and D.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
S.Con.Res 11- The Senate Budget Resolution - Issues that could impact insurance plans, transparency, health IT, health care entitlements and private coverage.
H.Con. Res. 96 - The House Budget Resolution - Issues that could impact, insurance plans, transparency and health IT. health care entitlements and private coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2- The Medicare Access and CHIP Reauthorization Act of 2015 - Issues related to physician reimbursement structure changes that can impact their interactions with health plans and delivery system reform.
CMS regulations related to payment and structure of Medicare Parts C and D as well as federal and state based Marketplaces.
HHS regulations related to health insurance market reforms.
Policies that would help to advance and improve access and coverage for palliative and end of life care in Medicare, Medicaid and the private insurance market.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Jan. 14, 2015.
Original Filing: 300695896.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern insurance cover in and outside of the Exchanges.
Issues related to upcoming regulations applying to the structure of the health insurer tax included in the ACA.
CMS Regulations related to the construct of Medicare Part C&D.
S. 1439 - Care Planning Act of 2013 - Focused on policies that would help to advance and improve the state of palliative care in the nation.
HHS regulations related to health insurance market reforms and roll out of the new Insurance Exchanges.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Focus on pending tax reform legislation and its impact on the 833(b) program, which relates to the tax treatment of certain not-for-profit Blue plans.
The Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (S. 2157) - support for delivery system reform incorporated into this piece of legislation.
H.R. 4994 - The IMPACT Act of 2014 - focused on including policies related to amending the 833(b) program.
H.R. 83- The Consolidated and Further Continuing Appropriations Act of 2015 - Provisions related to amending the 833(b) program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
CMS Regulations related to the construct of Medicare Hospice and the treatment of prescription medications.
S. 1439 - Care Planning Act of 2013 - Focused on policies that would help to advance and improve the state of palliative care in the nation.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
The Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (S. 2157) - support for delivery system reform incorporated into this piece of legislation.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Oct. 14, 2014.
Original Filing: 300676134.xml
Lobbying Issues
Issues related to the Health Reform Law's implementation with a specific focus on the regulations governing the new state-based and federally facilitated marketplaces.
Issues related to the treatment of affinity-based plans under the ACA.
Issues related to the coverage of palliative care for individuals and their families.
Issues related to legislation concerning the 833(b) tax regime.
CMS regulations impacting Medicare Parts C&D.
Issues related to transparency of data in the health care system.
Issues related to specialty pharmacy.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 2260 - Expiring Provision Improvement Reform and Efficiency Act (the Expire Act)Working with Congress to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2014
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on July 7, 2014.
Original Filing: 300653805.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern the new state-based health insurance market place and affinity health plans.
Issues related to upcoming regulations applying to the structure of the health insurer tax included in the ACA.
CMS Regulations related to the construct of Medicare Part C&DS. 1439 - Care Planning Act of 2013 - Focused on policies that would help to advance and improve the state of palliative care in the nation.
HHS regulations related to health insurance market reforms and roll out of the new Insurance Exchanges.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Focus on pending tax reform legislation and its impact on the 833(b) program, which relates to the tax treatment of certain not-for-profit Blue plans.
S. 2157 - The Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (S. 2157) - support for delivery system reform incorporated into this piece of legislation.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act and to maintain the current program within the context of potential tax reform legislation.
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2014
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on April 3, 2014.
Original Filing: 300632484.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern the new state-based health insurance market place and affinity health plans.
Issues related to upcoming regulations applying to the structure of the health insurer tax included in the ACA.
CMS Regulations related to the construct of Medicare Part C&DMedicare Part D call letter for 2015 submissions.
HHS regulations related to health insurance market reforms and roll out of the new Insurance Exchanges.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Focus on pending tax reform legislation and its impact on the 833(b) program, which relates to the tax treatment of certain not-for-profit Blue plans.
S. 2157 - The Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (S. 2157) - support for delivery system reform incorporated into this piece of legislation.
H.R. 4302 - SGR Patch Legislation - Concern about a provision delaying ICD-10 coding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act and to maintain the current program within the context of potential tax reform legislation.
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2013
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Jan. 9, 2014.
Original Filing: 300612178.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern the new state-based health insurance market place and affinity health plans.
Issues related to upcoming regulations applying to the structure of the health insurer tax included in the ACA.
HJ Res 59 - Continuing Resolution - issues impacting insurance plans and their interface with the federal governmentAmendment to H.J. Res 59 - Bipartisan Budget Act of 2013- provisions related health insurance, Medicare and Medicaid
HHS regulations related to health insurance market reforms and roll out of the new Insurance Exchanges.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Focus on pending tax reform legislation and its impact on the 833(b) program, which relates to the tax treatment of certain not-for-profit Blue plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act and to maintain the current program within the context of potential tax reform legislation.H.R. 8 - American Taxpayer Relief Act of 2012. Promulgation of the law specifically elements of the law that relate to the treatment of health insurers, Medicare Advantage and provisions focused on coverage.
S. Con. Res. 8 - Senate Budget Resolution - Focus on issues in the Medicare, Medicaid and Tax space that relate to insurance delivery.
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Oct. 15, 2013.
Original Filing: 300593963.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern the new state-based health insurance market place and affinity health plans.
Issues related to upcoming regulations applying to the structure of the health insurer tax included in the ACA.
HJ Res 59 - Continuing Resolution - issues impacting insurance plans and their interface with the federal governmentHHS regulations related to health insurance market reforms, essential health benefits and rate review for insurers in upcoming Exchanges.
H.R. 8 - American Taxpayer Relief Act of 2012. Promulgation of the law specifically elements of the law that relate to the treatment of heath insurers, Medicare Advantage and provisions focused on coverage.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Focus on pending tax reform legislation and its impact on the 833(b) program, which relates to the tax treatment of certain not-for-profit Blue plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act and to maintain the current program within the context of potential tax reform legislation.H.R. 8 - American Taxpayer Relief Act of 2012. Promulgation of the law specifically elements of the law that relate to the treatment of health insurers, Medicare Advantage and provisions focused on coverage.
S. Con. Res. 8 - Senate Budget Resolution - Focus on issues in the Medicare, Medicaid and Tax space that relate to insurance delivery.
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on July 9, 2013.
Original Filing: 300569954.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern the new state-based health insurance market place and affinity health plans.
Issues related to upcoming regulations applying to the structure of the health insurer tax included in the ACA.HHS regulations related to health insurance market reforms, essential health benefits and rate review for insurers in upcoming Exchanges.
H.R. 8 - American Taxpayer Relief Act of 2012. Promulgation of the law specifically elements of the law that relate to the treatment of heath insurers, Medicare Advantage and provisions focused on coverage.
ACA-related regulations promulgated by the Department of Health and Human Services and CMS regarding program integrity within the Exchanges with regard to product design.
Focus on pending tax reform legislation and its impact on the 833(b) program, which relates to the tax treatment of certain not-for-profit Blue plans.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act and to maintain the current program within the context of potential tax reform legislation.H.R. 8 - American Taxpayer Relief Act of 2012. Promulgation of the law specifically elements of the law that relate to the treatment of health insurers, Medicare Advantage and provisions focused on coverage.
S. Con. Res. 8 - Senate Budget Resolution - Focus on issues in the Medicare, Medicaid and Tax space that relate to insurance delivery.
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
In Q1, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on April 15, 2013.
Original Filing: 300550123.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the regulations to govern the new state-based health insurance market place and affinity health plans.
Issues related to upcoming regulations applying to the structure of the health insurer tax included in the ACA.HHS regulations related to health insurance market reforms, essential health benefits and rate review for insurers in upcoming Exchanges.
H.R. 8 - American Taxpayer Relief Act of 2012. Promulgation of the law specifically elements of the law that relate to the treatment of helath insurers, Medicare Advantage and provisions focused on coverage.
S. Con. Res. 8 - Senate Budget Resolution - Focus on issues in the Medicare, Medicaid and Tax space that relate to insurance delivery.
H.R. 527 - Continuing Resolution to ensure the complete and timely payment of obligations of the United States Government until May 19th.
H. R. 933 - Consolidation and Further Continuing Appropriations Act of 2013.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act.H.R. 8 - American Taxpayer Relief Act of 2012. Promulgation of the law specifically elements of the law that relate to the treatment of health insurers, Medicare Advantage and provisions focused on coverage.
S. Con. Res. 8 - Senate Budget Resolution - Focus on issues in the Medicare, Medicaid and Tax space that relate to insurance delivery.
H.R. 527 - Continuing Resolution to ensure the complete and timely payment of obligations of the United States Government until May 19th.
H. R. 933 - Consolidation and Further Continuing Appropriations Act of 2013.
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2012
In Q4, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Jan. 7, 2013.
Original Filing: 300526207.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges and affinity health plans.
P.L. 112-25- Budget Control Act of 2011. Monitoring the bill/law's progress and impact on Medicare and private insurance programsHHS regulations related to health insurance market reforms, essential health benefits and rate review for insurers in upcoming Exchanges.
H.R. 8 - American Taxpayer Relief Act of 2012. Specifically elements of the bill ( now law) that relate to the treatment of helath insurers, Medicare Advantage and provisions focused on coverage.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2012
In Q3, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on Oct. 11, 2012.
Original Filing: 300505250.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges and affinity health plans.
P.L. 112-25- Budget Control Act of 2011. Monitoring the bill/law's progress and impact on Medicare and private insurance programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2012
In Q2, Nathanson+Hauck lobbied for Cambia Health Solutions (formerly known as The Regence Group) , earning $60,000. The report was filed on July 3, 2012.
Original Filing: 300480535.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges and affinity health plans. Also focused on the 833(b) program changes in the ACA.
P.L. 112-25- Budget Control Act of 2011. Monitoring the bill/law's progress and impact on Medicare and private insurance programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Working with the Administration and Senate to remedy issues related to the 833(b) program, which was amended in the Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2012
Nathanson+Hauck amended a lobbying report for representation of Cambia Health Solutions (formerly known as The Regence Group) in Q12012 on April 5, 2012.
Original Filing: 300457799.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges and affinity health plans.
P.L. 112-25- Budget Control Act of 2011. Monitoring the bill/law's progress and impact on Medicare and private insurance programsH.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011-2012- Monitoring legislation for potential provisions impacting Medigap and tax exempt status for not-for-profit insurance plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011-2012 - Monitoring legislation for potential provisions impacting the Medigap program in Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011-2012 - Monitoring legislation for potential provisions impacting tax exempt status for not-for-profit insurance plans, specifically the 833(b) exemption.
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2012
In Q1, Nathanson+Hauck lobbied for The Regence Group , earning $60,000. The report was filed on April 3, 2012.
Original Filing: 300457385.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges and affinity health plans.
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011 - Monitoring legislation for potential provisions impacting Medigap and tax exempt status for not-for-profit insurance plans.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011 - Monitoring legislation for potential provisions impacting the Medigap program in Medicare.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011 - Monitoring legislation for potential provisions impacting tax exempt status for not-for-profit insurance plans, specifically the 833(b) exemption.
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2011
In Q4, Nathanson+Hauck lobbied for The Regence Group , earning $60,000. The report was filed on Dec. 29, 2011.
Original Filing: 300433892.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges and affinity health plans.
P.L. 112-25- Budget Control Act of 2011. Monitoring the bill/law's progress and impact on Medicare and private insurance programsH.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011 - Monitoring legislation for potential provisions impacting Medigap and tax exempt status for not-for-profit insurance plans
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011 - Monitoring legislation for potential provisions impacting the Medigap program in Medicare.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 3630 (S. Amdt. 1465) - Temporary Payroll Tax Cut Continuation Act of 2011 - Monitoring legislation for potential provisions impacting tax exempt status for not-for-profit insurance plans, specifically the 833(b) exemption.
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2011
In Q3, Nathanson+Hauck lobbied for The Regence Group , earning $60,000. The report was filed on Oct. 10, 2011.
Original Filing: 300411824.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges and affinity health plans.
P.L. 112-25- Budget Control Act of 2011. Monitoring the bill/law's progress and impact on Medicare and private insurance programs
Agencies Lobbied
U.S. Senate
2nd Quarter, 2011
Nathanson+Hauck amended a lobbying report for representation of The Regence Group in Q22011 on July 5, 2011.
Original Filing: 300386081.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern the new state-based health insurance Exchanges.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2011
In Q2, Nathanson+Hauck lobbied for The Regence Group , earning $50,000. The report was filed on July 1, 2011.
Original Filing: 300385846.xml
Lobbying Issues
Issues related to Health Reform Law implementation with a specific focus on the upcoming regulations to govern new state-based health insurance Exchanges.
Agencies Lobbied
U.S. Senate
1st Quarter, 2011
Nathanson+Hauck amended a lobbying report for representation of The Regence Group in Q12011 on April 6, 2011.
Original Filing: 300360447.xml
Lobbying Issues
Health Reform Law implementation regulations with a focus on the treatment of Pharmacy Benefit Managers in the Medical Loss Ratio (MLR) rule.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Nathanson+Hauck lobbied for The Regence Group , earning $17,500. The report was filed on April 5, 2011.
Original Filing: 300360092.xml
Lobbying Issues
Affordable Care Act issues related to regulations regarding plans covered inside and outside of the new insurance Exchanges.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
Nathanson+Hauck filed a lobbying registration on March 20, 2011 to represent The Regence Group, effective March 1, 2011.
Original Filing: 300359087.xml
Issue(s) they said they’d lobby about: Implementation of Health Reform Law and related legislative amendments to the law. Health insurance related items in both the private insurance arena as well as the entitlements. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...